Medtronic Historical Income Statement

MDT Stock

USD 86.27 0.59 0.69%

Historical analysis of Medtronic PLC income statement accounts such as Gross Profit of 22.2 B can show how well Medtronic PLC performed in making a profits. Evaluating Medtronic PLC income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Medtronic PLC's future profits or losses.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Medtronic PLC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medtronic PLC is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.

For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

About Medtronic Income Statement Analysis

Medtronic PLC Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Medtronic PLC shareholders. The income statement also shows Medtronic investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Medtronic PLC Income Statement Chart

At this time, Medtronic PLC's Net Income From Continuing Ops is comparatively stable compared to the past year. Non Operating Income Net Other is likely to gain to about 621.9 M in 2024, whereas EBITDA is likely to drop slightly above 4.6 B in 2024.

Total Revenue Gross Profit Other Operating Expenses Operating Income

Total Revenue

Total revenue comprises all receipts Medtronic PLC generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Medtronic PLC minus its cost of goods sold. It is profit before Medtronic PLC operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Medtronic PLC. It is also known as Medtronic PLC overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Medtronic PLC operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Medtronic PLC is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from Medtronic PLC's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Medtronic PLC current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.

For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.At this time, Medtronic PLC's Net Income From Continuing Ops is comparatively stable compared to the past year. Non Operating Income Net Other is likely to gain to about 621.9 M in 2024, whereas EBITDA is likely to drop slightly above 4.6 B in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	21.5B	20.5B	21.1B	22.2B
Total Revenue	31.7B	31.2B	32.4B	34.0B

Gross Profit Total Revenue

Medtronic PLC income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Research Development	Selling General Administrative	Net Income From Continuing Ops	Non Recurring	Minority Interest	Tax Provision	Non Operating Income Net Other	Interest Income	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.8	0.93	0.91	0.94	0.62	0.6	0.77	0.94	0.93	0.6	-0.11	0.64	0.08	0.82	0.86	0.71	-0.81	-0.44	-0.15	0.47	-0.75	-0.27	-0.55
Interest Expense	0.8		0.72	0.74	0.7	0.63	0.65	0.76	0.68	0.71	0.52	-0.16	0.52	0.11	0.62	0.7	0.44	-0.68	0.04	-0.05	0.1	-0.35	-0.55	-0.27
Total Revenue	0.93	0.72		0.99	1.0	0.72	0.72	0.81	0.98	1.0	0.72	-0.08	0.68	0.29	0.88	0.92	0.62	-0.83	-0.48	0.01	0.51	-0.74	-0.17	-0.61
Gross Profit	0.91	0.74	0.99		0.98	0.78	0.78	0.85	0.96	0.99	0.78	-0.09	0.72	0.3	0.88	0.93	0.6	-0.79	-0.44	0.02	0.45	-0.7	-0.19	-0.56
Other Operating Expenses	0.94	0.7	1.0	0.98		0.66	0.66	0.77	0.99	1.0	0.67	-0.06	0.63	0.26	0.86	0.89	0.63	-0.86	-0.52	-0.01	0.56	-0.78	-0.16	-0.65
Operating Income	0.62	0.63	0.72	0.78	0.66		0.94	0.93	0.6	0.7	0.98	0.02	0.85	0.39	0.85	0.89	0.34	-0.45	-0.12	0.23	0.02	-0.33	-0.19	-0.06
Ebit	0.6	0.65	0.72	0.78	0.66	0.94		0.96	0.6	0.69	0.93	-0.22	0.83	0.32	0.82	0.87	0.32	-0.46	-0.03	0.15	0.0	-0.24	-0.14	0.0
Ebitda	0.77	0.76	0.81	0.85	0.77	0.93	0.96		0.72	0.79	0.91	-0.2	0.86	0.22	0.92	0.95	0.47	-0.6	-0.13	0.05	0.11	-0.4	-0.21	-0.08
Cost Of Revenue	0.94	0.68	0.98	0.96	0.99	0.6	0.6	0.72		0.98	0.61	-0.06	0.58	0.25	0.84	0.86	0.62	-0.88	-0.54	-0.02	0.59	-0.8	-0.13	-0.66
Total Operating Expenses	0.93	0.71	1.0	0.99	1.0	0.7	0.69	0.79	0.98		0.7	-0.05	0.67	0.27	0.87	0.9	0.63	-0.83	-0.5	-0.01	0.53	-0.76	-0.18	-0.64
Income Before Tax	0.6	0.52	0.72	0.78	0.67	0.98	0.93	0.91	0.61	0.7		0.04	0.85	0.42	0.87	0.89	0.34	-0.46	-0.23	0.26	0.09	-0.38	-0.08	-0.08
Total Other Income Expense Net	-0.11	-0.16	-0.08	-0.09	-0.06	0.02	-0.22	-0.2	-0.06	-0.05	0.04		-0.18	0.39	-0.07	-0.11	0.05	-0.01	-0.22	0.47	0.13	-0.15	-0.09	-0.3
Net Income	0.64	0.52	0.68	0.72	0.63	0.85	0.83	0.86	0.58	0.67	0.85	-0.18		-0.1	0.84	0.85	0.62	-0.34	-0.22	-0.28	0.27	-0.3	-0.29	-0.05
Income Tax Expense	0.08	0.11	0.29	0.3	0.26	0.39	0.32	0.22	0.25	0.27	0.42	0.39	-0.1		0.2	0.23	-0.35	-0.32	-0.14	0.94	-0.21	-0.28	0.35	-0.24
Research Development	0.82	0.62	0.88	0.88	0.86	0.85	0.82	0.92	0.84	0.87	0.87	-0.07	0.84	0.2		0.98	0.54	-0.7	-0.39	0.02	0.41	-0.58	-0.12	-0.25
Selling General Administrative	0.86	0.7	0.92	0.93	0.89	0.89	0.87	0.95	0.86	0.9	0.89	-0.11	0.85	0.23	0.98		0.55	-0.68	-0.33	0.02	0.36	-0.61	-0.21	-0.3
Net Income From Continuing Ops	0.71	0.44	0.62	0.6	0.63	0.34	0.32	0.47	0.62	0.63	0.34	0.05	0.62	-0.35	0.54	0.55		-0.43	-0.54	-0.5	0.62	-0.56	-0.38	-0.5
Non Recurring	-0.81	-0.68	-0.83	-0.79	-0.86	-0.45	-0.46	-0.6	-0.88	-0.83	-0.46	-0.01	-0.34	-0.32	-0.7	-0.68	-0.43		0.45	-0.12	-0.45	0.65	0.08	0.54
Minority Interest	-0.44	0.04	-0.48	-0.44	-0.52	-0.12	-0.03	-0.13	-0.54	-0.5	-0.23	-0.22	-0.22	-0.14	-0.39	-0.33	-0.54	0.45		0.0	-0.69	0.73	-0.25	0.62
Tax Provision	-0.15	-0.05	0.01	0.02	-0.01	0.23	0.15	0.05	-0.02	-0.01	0.26	0.47	-0.28	0.94	0.02	0.02	-0.5	-0.12	0.0		-0.38	-0.1	0.39	0.0
Non Operating Income Net Other	0.47	0.1	0.51	0.45	0.56	0.02	0.0	0.11	0.59	0.53	0.09	0.13	0.27	-0.21	0.41	0.36	0.62	-0.45	-0.69	-0.38		-0.6	-0.23	-0.66
Interest Income	-0.75	-0.35	-0.74	-0.7	-0.78	-0.33	-0.24	-0.4	-0.8	-0.76	-0.38	-0.15	-0.3	-0.28	-0.58	-0.61	-0.56	0.65	0.73	-0.1	-0.6		0.02	0.74
Net Interest Income	-0.27	-0.55	-0.17	-0.19	-0.16	-0.19	-0.14	-0.21	-0.13	-0.18	-0.08	-0.09	-0.29	0.35	-0.12	-0.21	-0.38	0.08	-0.25	0.39	-0.23	0.02		0.19
Reconciled Depreciation	-0.55	-0.27	-0.61	-0.56	-0.65	-0.06	0.0	-0.08	-0.66	-0.64	-0.08	-0.3	-0.05	-0.24	-0.25	-0.3	-0.5	0.54	0.62	0.0	-0.66	0.74	0.19

Click cells to compare fundamentals

Medtronic PLC Account Relationship Matchups

Medtronic PLC income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	3.5B	2.7B	2.7B	2.7B	2.6B	2.8B
Interest Expense	1.1B	925M	553M	636M	719M	755.0M
Total Revenue	28.9B	30.1B	31.7B	31.2B	32.4B	34.0B
Gross Profit	19.5B	19.6B	21.5B	20.5B	21.1B	22.2B
Other Operating Expenses	23.7B	25.2B	25.8B	25.4B	27.2B	28.6B
Operating Income	4.8B	4.5B	5.8B	5.5B	5.1B	3.0B
Ebit	4.8B	5.5B	6.8B	5.8B	5.6B	3.6B
Ebitda	8.2B	8.2B	9.6B	8.5B	8.2B	4.6B
Cost Of Revenue	9.4B	10.5B	10.1B	10.7B	11.2B	11.8B
Total Operating Expenses	14.3B	14.7B	15.6B	14.7B	16.1B	16.9B
Income Before Tax	4.1B	3.9B	5.5B	5.4B	4.8B	2.7B
Total Other Income Expense Net	(736M)	(589M)	(235M)	(121M)	(307M)	(322.4M)
Net Income	4.8B	3.6B	5.0B	3.8B	3.7B	2.2B
Income Tax Expense	(751M)	265M	456M	1.6B	1.1B	1.2B
Research Development	2.3B	2.5B	2.7B	2.7B	2.7B	1.5B
Selling General Administrative	9.9B	10.1B	10.3B	10.4B	10.7B	7.7B
Net Income Applicable To Common Shares	4.8B	3.6B	5.0B	3.8B	4.3B	3.2B
Net Income From Continuing Ops	4.8B	3.6B	5.1B	3.8B	3.7B	4.2B
Non Recurring	313M	118M	95M	(30M)	(27M)	(25.7M)
Minority Interest	17M	174M	(22M)	(26M)	(28M)	(26.6M)
Tax Provision	(751M)	265M	456M	1.6B	1.1B	639.8M
Non Operating Income Net Other	356M	336M	318M	515M	592.3M	621.9M
Interest Income	379M	617M	541M	164M	147.6M	140.2M
Extraordinary Items	(2.3B)	(12M)	63M	106M	121.9M	128.0M
Net Interest Income	(1.1B)	(925M)	(553M)	(636M)	(719M)	(755.0M)
Reconciled Depreciation	2.7B	2.7B	2.7B	2.7B	2.6B	2.2B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Medtronic Stock Analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medtronic Historical Income Statement

About Medtronic Income Statement Analysis

Medtronic PLC Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Operating Income

Medtronic PLC income statement Correlations

Medtronic PLC Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Medtronic PLC income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Medtronic Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Gross Profit	+ 0.99	Total Revenue
Total Operating Expenses	+ 0.99	Gross Profit
Cost Of Revenue	+ 0.99	Other Operating Expenses

Non Recurring	- 0.88	Cost Of Revenue
Non Recurring	- 0.86	Other Operating Expenses
Non Recurring	- 0.83	Total Operating Expenses
Non Recurring	- 0.83	Total Revenue
Non Recurring	- 0.81	Depreciation And Amortization
Interest Income	- 0.8	Cost Of Revenue